Literature DB >> 19755545

Recommendations for the administration of influenza vaccine in children allergic to egg.

M Erlewyn-Lajeunesse1, N Brathwaite, J S A Lucas, J O Warner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19755545     DOI： 10.1136/bmj.b3680

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus.

Authors:  Pei-Feng Liu; Yanhan Wang; Yu-Tsueng Liu; Chun-Ming Huang
Journal:  J Nat Sci       Date:  2017-02

2.  No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients.

Authors:  Julia Elizabeth Mainwaring Upton; David Brian Hummel; Anna Kasprzak; Adelle Roberta Atkinson
Journal:  Allergy Asthma Clin Immunol       Date:  2012-03-02       Impact factor: 3.406

3.  Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease.

Authors:  Jane E Schuler; W James King; Natalie L Dayneka; Lynn Rastelli; Evelyn Marquis; Zave Chad; Charles Hui
Journal:  Can J Public Health       Date:  2011 May-Jun

Review 4.  [Anaphylactic reactions to vaccines : Chicken egg allergy and the influenza H1N1 vaccination].

Authors:  L Klimek; S Wicht-Langhammer; L von Bernus; C Thorn; D Cazan; O Pfaar; K Hörmann
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

5.  Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines.

Authors:  Florian Krammer; Theresa Schinko; Dieter Palmberger; Christopher Tauer; Paul Messner; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

6.  Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.

Authors:  Claire S Waddington; W T Walker; C Oeser; A Reiner; T John; S Wilkins; M Casey; P E Eccleston; R J Allen; I Okike; S Ladhani; E Sheasby; K Hoschler; N Andrews; P Waight; A C Collinson; P T Heath; A Finn; S N Faust; M D Snape; E Miller; A J Pollard
Journal:  BMJ       Date:  2010-05-27

Review 7.  Preparing next-generation scientists for biomedical big data: artificial intelligence approaches.

Authors:  Jason H Moore; Mary Regina Boland; Pablo G Camara; Hannah Chervitz; Graciela Gonzalez; Blanca E Himes; Dokyoon Kim; Danielle L Mowery; Marylyn D Ritchie; Li Shen; Ryan J Urbanowicz; John H Holmes
Journal:  Per Med       Date:  2019-02-14       Impact factor: 2.512

8.  Reactions of Norwegian children with severe egg allergy to an egg-containing influenza A (H1N1) vaccine: a retrospective audit.

Authors:  Bård Anders Forsdahl
Journal:  BMJ Open       Date:  2012-01-05       Impact factor: 2.692

9.  Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.

Authors:  Lisa A Grohskopf; Sonja J Olsen; Leslie Z Sokolow; Joseph S Bresee; Nancy J Cox; Karen R Broder; Ruth A Karron; Emmanuel B Walter
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-08-15       Impact factor: 17.586

10.  The Saudi Thoracic Society guidelines for influenza vaccinations.

Authors:  Mohammed O Zeitouni; Ali M Al Barrak; Mohamed S Al-Moamary; Nasser S Alharbi; Majdy M Idrees; Abdullah A Al Shimemeri; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.